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ONCOLOGYSexual Dysfunction and Reproductive Concerns in Young Men
Diagnosed With Testicular Cancer: An Observational StudyL. Ljungman, PhD,1 L. E. Eriksson, PhD,2,3,4 K. E. Flynn, PhD,5 J. R. Gorman, PhD,6 O. Ståhl, PhD,7
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J Sex MedIntroduction: The survival rates for testicular cancer are excellent; still, there is a lack of knowledge regarding
important survivorship issues, such as sexual dysfunction and reproductive concerns.
Aim: The aim of this study was to investigate the prevalence and predictors of sexual dysfunction and repro-
ductive concerns and the potential association between these issues in young men w2 years after a diagnosis of
testicular cancer.
Methods: Data were collected from 111 men (response rate ¼ 50%) diagnosed with testicular cancer at age
16e39. Patients were identiﬁed via the Swedish National Quality Registry for Testicular Cancer and approached
with a survey, including standardized measures of sexual function, reproductive concerns, body image, and
health-related quality of life. The survey was sent to participants approximately 2 years after their cancer diag-
nosis. Clinical variables were collected from the registry. Predictors were identiﬁed by multivariable linear
regression analyses.
Main Outcome Measures: The main outcomes were sexual function, assessed with the Patient-Reported
Outcomes Measurement Information System Sexual Function and Satisfaction measure version 2.0, and
reproductive concerns, assessed with the Reproductive Concerns After Cancer scale.
Results: Sexual dysfunctionwas reported by 26%ofmen, and a high level of reproductive concerns was reported by
28%. Lower satisfaction with sex life was associated with older age (b¼0.41), negative body image (b¼0.42),
not having a partner (b¼ 4.8), and dissatisfaction with sex life before cancer (b¼ 8.31). Negative body image was
associated with reproductive concerns in the dimensions of fertility potential (b ¼ 0.06), partner disclosure
(b ¼ 0.08), and child’s health (b ¼ 0.07), whereas having had fertility preservation predicted higher levels of
concerns with regard to personal health (b¼ 0.52) and achieving pregnancy (b¼ 0.53). Clinical variables did not
predict either sexual function or reproductive concerns.
Clinical Implications: Our results show that the majority of young men diagnosed with testicular cancer do not
report sexual dysfunction or reproductive concerns 2 years after diagnosis. A sizeable minority, however, does
report dysfunction or reproductive concerns, which should be recognized in the follow-up care of this population.
Strengths & Limitations: A strength of the study is the use of high-quality registry data and validated in-
struments. The lack of Swedish norms for sexual function and reproductive concerns is a possible limitation.
Conclusion: A subgroup of young men treated for testicular cancer report sexual dysfunction or reproductive
concerns approximately 2 years after diagnosis. Factors associated with these issues seem to mainly be psycho-
logical, rather than medical, nature. Ljungman L, Eriksson LE, Flynn KE, et al. Sexual Dysfunction andbruary 14, 2019. Accepted May 6, 2019.
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Testicular cancer is the most common cancer among young
men.1 It is also one of the most curable cancers, with a 5-year
survival rate of 97% in countries providing adequate oncology
care.2 Because the disease affects the reproductive organs, sexual
dysfunction and concerns related to fertility are crucial aspects to
take into consideration in survivorship care.
In a review of the literature, Carpentier and Fortenberry3
found that survivors of testicular cancer reported higher levels
of sexual dysfunction than healthy control subjects, including
decreased sexual enjoyment, decreased desire, and erectile and
ejaculatory dysfunction. These problems have been reported to
persist up to 2 years after treatment; however, there are in-
consistencies in the previous literature with regard to the prev-
alence of these issues, and reliable data are lacking.4 Previous
studies have identiﬁed general anxiety, lower levels of testos-
terone, older age, radiation therapy in combination with
chemotherapy, or retroperitoneal lymph node dissection
(RPLND) as predictors of sexual problems after testicular can-
cer.5,6 Additionally, non-partnered compared with partnered
survivors have reported more erectile and orgasmic dysfunction
and lower levels of sexual satisfaction.3,5 To increase knowledge
about predictors of sexual problems in this population,
researchers in the ﬁeld have underscored the importance of
analyzing different types of sexual problems separately
(eg, erectile/ejaculatory function and satisfaction with sex life),
because these may well be explained by different factors.4,7 It has
also been suggested that, aside from retrograde ejaculation, which
is related to having had RPLND, psychological mechanisms may
be the most important for explaining the development and
persistence of sexual dysfunction after testicular cancer.8
Negative body image has been identiﬁed as a psychological
mechanism potentially involved in sexual dysfunction after
cancer.3,9 Body image is a concept that includes affective
(eg, feeling masculine/feminine), behavioral (eg, avoiding people
because of appearance), and cognitive (eg, dissatisfaction with
appearance or with scars) aspects of experiences related to one’s
own body.10,11 In a previous publication, 17% of men treated
for testicular cancer reported a negative change in masculinity,
which also was related to higher levels of sexual problems.8 The
authors argued that this ﬁnding could be explained by the testes
being associated with symbolism and fantasies of masculinity and
physical strength. Overall, though, the impact of psychological
factors, such as negative body image and masculinity on sexualproblems after testicular cancer in young men, has not been
sufﬁciently described in the literature.9,12
Fertility is estimated to be reduced by approximately 30%
after testicular cancer.13,14 Even though cryopreservation is rec-
ommended for patients with cancer who are receiving highly
toxic treatment, the proportion of patients who actually use
sperm banking varies signiﬁcantly among countries.15,16 Fear of
infertility, or knowing that one’s fertility has been compromised,
has been associated with negative effects on identity, masculinity,
and psychological well-being in men diagnosed with cancer.17
Fertility preservation has, in qualitative research, been sug-
gested to function as a buffer against anxiety about possible
future infertility.18,19
Reproductive concerns after cancer include not only concerns
regarding fertility potential, but also concerns regarding
parenthood-related factors, such as living long enough to raise
children, genetic predisposition of cancer in one’s offspring,
discussing fertility problems with a partner, and acceptance of
possible infertility.20,21 In women with cancer, reproductive
concerns have been associated with decreased quality of life and
depressive symptoms,22,23 and the prevalence of this type of
concern has been reported to be as high as 60e65% in young
women with breast cancer.24,25 The prevalence of reproductive
concerns has, to the best of our knowledge, not yet been
examined in young men with testicular cancer.
Because adolescence and young adulthood are developmental
periods, including speciﬁc tasks such as identity exploration,
establishment of close intimate relationships, and family building,3
receiving a diagnosis of testicular cancer during these periods may
affect men’s feelings regarding their masculinity, attractiveness,
fertility, sexuality, and romantic relationships. However, there is a
lack of ﬁrm knowledge regarding sexual problems and reproductive
concerns in young men diagnosed with testicular cancer. Besides
the small number of studies investigating these issues, the use of
non-validated measures and the absence of reliable norms for
comparison contribute further to the gap in knowledge.4,7,26
Furthermore, the mechanisms involved in these issues, and the
association between sexual problems and reproductive concerns,
has not been described. The overall aim of this study was
therefore to investigate the prevalence and predictors of sexual
dysfunction and reproductive concerns in young men approxi-
mately 2 years after being diagnosed with testicular cancer. An
additional aim was to identify the potential interdependence
between these issues.J Sex Med 2019;16:1049e1059
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1. What is the prevalence of sexual dysfunction and reproductive
concerns in young men (16e39 years) diagnosed with
testicular cancer w2 years previously?
2. Is there an association between sexual function and repro-
ductive concerns in this group?
3. What are the predictors of sexual dysfunction and reproduc-
tive concerns in this group?METHODS
Study Design
The study was an observational prospective study using pa-
tient self-reported survey data to measure the outcome variables
and registry data to measure the predictor variables.Setting, Participants, and Procedure
Men diagnosed with testicular cancer at the age of 16e39 in
Sweden (from July 2014eJune 2015) were identiﬁed using the
Swedish nationwide high-quality registry for testicular cancer,
“SWENOTECA,”which has a coverage of 98% of all new cases of
testicular cancer in Sweden. Through linkage with the Swedish
population registry, information on vital status and address details
were collected. Men with no address information were excluded.
At the time of survey data collection, participants were 1.5e2.5
years after diagnosis (mean 739, SD 106, range 550e914 days).
The survey was sent by mail to potential participants together
with information about the study and a prepaid envelope for
questionnaire return. Individuals who did not respond received 2
reminders, which were also sent by mail. By responding to the
survey, participants gave their consent to participate in the study.
Informed consent was thereby obtained from all individual
participants included in the study.
No compensation was given for study participation. Ethical
approval was obtained for the study procedures by the Regional
Ethical Review Board in Stockholm, Sweden (Ref No:
20131746-31/4). In parallel to this study, a corresponding study
with similar aims and procedures was conducted targeting young
women diagnosed with breast cancer.24
Treatment
Treatment for testicular cancer in Sweden is given according
to the national SWENOTECA guidelines (www.swenoteca.org):
All patients undergo unilateral orchiectomy. Patients with clin-
ical stage I (conﬁned only to the tumor-bearing testicle) are
monitored by surveillance or receive 1 cycle of adjuvant
chemotherapy. Disseminated disease (>stage I) is typically
treated with chemotherapy; standard treatment is 3 cycles. Non-
seminoma patients with residual disease after chemotherapy may
receive additional surgery, most often RPLND. Radiotherapy is
less commonly used and is reserved for speciﬁc clinical situations,
either replacing chemotherapy or, in very advanced cases, givenJ Sex Med 2019;16:1049e1059as an additional treatment. Before the start of treatment, cryo-
preservation of sperm is offered free of charge to all men diag-
nosed with testicular cancer in Sweden.Measures
Registry Data
Data collected from the testicular cancer registry included
personal identiﬁcation number, age at diagnosis, date of diagnosis,
tumor type, clinical stage classiﬁcation, and type(s) of treatment.Survey
Sociodemographic Variables
Study-speciﬁc questions were used to assess sociodemographic
information, including birth country, education, employment,
family situation (partner, children), sexual orientation, and wish
for (additional) children. Additionally, information about any
current cancer treatment and fertility preservation were collected.
Sexual Function
Sexual function was assessed using the Patient-Reported
Outcomes Measurement Information System (PROMIS) Sex-
ual Function and Satisfaction measure version 2.0 (SexFS).27
The SexFS has demonstrated content and construct validity
and test-retest reliability in the United States.27,28 For the pur-
pose of the current study, the following 3 SexFS domains were
selected: “Erectile function,” “Interest in sexual activity,” and
“Satisfaction with sex life.” In each domain, scores are expressed
on a T-score metric, with 50 corresponding to the mean of the
population of U.S. adults who have been sexually active in the
past 30 days.27 A lower score indicates more problems in all
domains. We considered 1 SD (10 points on the T-scale) under
50 as indicative of dysfunction in the respective domain, which is
in accordance with the suggested interpretation of domain scores
by the PROMIS Network (http://www.nihpromis.org/). Ques-
tions concerning satisfaction with sex life before cancer and
reasons for not having had sexual activity with a partner during
the past 30 days were also included.
The current study and the corresponding study targeting
young women with breast cancer24 were the ﬁrst to use the
SexFS in Sweden, and we, therefore, translated the English
version of the instrument into Swedish. The translation of the
SexFS into Swedish was conducted in accordance with the
standardized procedure developed by FACITrans and PROMIS.
The procedure included a forward/backward translation, fol-
lowed by cognitive interviews with 22 adolescents and adults; the
sample included participants with experience of cancer.29 The
ﬁnal linguistically-validated version of a Swedish SexFS v2.0 has
been approved by the PROMIS Translation Director.
Reproductive Concerns
Reproductive concerns were assessed using the Reproductive
Concerns After Cancer scale (RCAC), which is amultidimensional
Table 1. Demographics and clinical variables for young men diagnosed with testicular cancer
Total (N ¼ 111) Age 31 (n ¼ 43) Age 32 (n ¼ 68)
Age, mean(SD) 32.1 (5.5) 26.6 (3.0) 36.1 (3.0)
Country of birth, n(%)
Sweden 101 (91.0) 42 (97.7) 59 (86.8)
Other 10 (9.0) 1 (2.3) 9 (13.2)
Education
University degree 53 (47.7) 24 (55.8) 29 (42.6)
Vocational status
Full-time employment 85 (76.6) 28 (65.1) 57 (83.8)
Currently on cancer treatment
Chemotherapy 0 (0) 0 (0) 0 (0)
Radiation therapy 0 (0) 0 (0) 0 (0)
Endocrine treatment 4 (3.6) 1 (2.4) 3 (4.4)
Other treatment 5 (4.5) 2 (4.8) 3 (4.4)
Tumor type
Seminom 68 (61.3) 17 (39.5) 51 (75.0)
Non-seminom 43 (38.7) 26 (60.5) 17 (25.0)
Stage of disease
Stage I 82 (75.9) 30 (73.2) 52 (77.6)
>Stage I 26 (24.1) 11 (26.8) 15 (22.4)
Chemotherapy* 55 (50) 22 (51.2) 33 (48.5)
Type of surgery
RPLND† 5 (4.5) 3 (7.0) 2 (2.9)
Fertility preservation
No 22 (20) 4 (9.3) 21 (32.3)
Yes 83 (80) 39 (90.7) 44 (67.7)
Have partner
Yes 90 (82) 32 (74.4) 58 (86.6)
Have children
Yes 53 (48.2) 10 (23.8) 43 (63.2)
Wish to have (additional) children in the future
Yes 71 (64.5) 35 (83.3) 36 (52.9)
Do not know/No 39 (35.5) 7 (16.7) 32 (47.1)
Sexual orientation
Heterosexual 104 (94.5) 42 (97.7) 62 (92.5)
Homosexual 3 (2.7) 1 (2.3) 2 (3.0)
Bisexual 1 (0.9) 0 (0) 1 (1.5)
Other 1 (0.9) 0 (0) 1 (1.5)
Do not want to declare 1 (0.9) 0 (0) 1 (1.5)
Satisfaction with sex life before cancer
High 85 (78.0) 35 (83.3) 50 (74.6)
Low 24 (22.0) 7 (16.7) 17 (25.4)
BIS, mean (SD)
Summary score 4.6 (6.2) 5.4 (5.9) 4.2 (6.4)
Number above cutoff‡ 15 (14.0) 7 (17.1) 8 (12.1)
QLQ-30, mean (SD)
Summary score 86.4 (13.1) 87.2 (12.7) 86.1 (13.4)
RCAC, mean (SD)
Fertility potential 2.4 (1.2) 2.6 (1.2) 2.2 (1.2)
Partner disclosure 2.3 (1.2) 2.5 (1.2) 2.2 (1.2)
Child’s health 2.5 (1.3) 2.8 (1.3) 2.4 (1.2)
Personal health 2.2 (0.9) 2.1 (1.0) 2.2 (1.0)
Acceptance 2.5 (1.1) 2.9 (1.1) 2.3 (1.0)
(continued)
J Sex Med 2019;16:1049e1059
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Table 1. Continued
Total (N ¼ 111) Age 31 (n ¼ 43) Age 32 (n ¼ 68)
Achieving pregnancy 2.2 (0.9) 2.3 (1.0) 2.1 (0.9)
Summary score 42.1 (14.0) 46.4 (13.2) 39.4 (14.0)
SexFS, mean (SD)
Erectile function 51.6 (6.6) 51.1 (7.0) 52.0 (6.4)
Satisfaction with sex life 49.8 (8.9) 50.9 (9.9) 49.1 (8.2)
Interest in sexual activity 51.5 (10.2) 52.8 (9.9) 50.6 (10.5)
BIS ¼ Body Image Scale; QLQ-30 ¼ EORTC QLQ-C30 version 3.0; RCAC ¼ Reproductive Concerns After Cancer; RPLND ¼ retroperitoneal lymph node
dissection; SexFS ¼ Sexual Function and Satisfaction measure version 2.0.
*Adjuvant chemotherapy was received by 64% (n ¼ 35).
†Among participants who had not completed fertility preservation 32% had a wish for children whereas among those who had completed fertility pres-
ervation 74% had a wish for children in the future.
‡Cut-off for BIS¼10.
Sex and Reproduction After Testicular Cancer 1053scale assessing a range of reproductive and parenthood concerns
after cancer.20 It includes 18 items scored on a 5-point response
scale ranging from 1 ¼ “Strongly disagree”e5¼ “Strongly agree”
and includes 6 dimensions, with 3 items per dimension: “Fertility
potential,” “Partner disclosure,” “Child’s health,” “Personal
health,” “Acceptance,” and “Achieving pregnancy.” Examples of
questions from the dimensions are “I am afraid I won’t be able to
have any (more) children” (Fertility potential), “I worry about
telling my (potential) spouse/partner that I may be unable to have
children” (Partner disclosure), “I am worried about passing on a
genetic risk for cancer to my children” (Child’s health), “I am
cautious about having (more) children because I might not be
around to raise them” (Personal health), “I can accept it if I’m
unable to have (more) children” (Acceptance), and “It is stressful to
think about trying to achieve a pregnancy (again)” (Achieving
pregnancy). The scale was initially developed and validated for use
with female young adult cancer survivors between the ages of
18e35.20 The scale was adapted for men based on expert opinion
and cognitive interviews with 10 young adult male cancer survi-
vors.30 The RCAC has demonstrated satisfactory internal consis-
tency and construct validity in women,25 and preliminarily results
indicate that the scale and the 6 subscales also have acceptable
internal consistency (0.74e0.92) in men.30 3 different reports of
the RCAC are used in the current study: (i) A mean value of>4 in
1 dimension to indicate a high level of reproductive concerns in
that respective area20; (ii)1 dimension with a mean value>4 to
indicate a high level of reproductive concerns overall; (iii) Total
scores as continuous measures of level of reproductive concerns
(within dimensions and as a summary of all items).
Because the current study and the corresponding study on
young women with breast cancer24 were the ﬁrst to use the RCAC
in Sweden, we translated the English version of the instrument
into Swedish. The translation process was conducted by a dual
panel as suggested by Swaine-Werdier et al.31 The scale was
independently translated into Swedish by 2 bilingual researchers,
evaluated by 2 lay panels and 1 patient panel, and tested in
cognitive interviews with 3 young persons with cancer. The eval-
uation indicated that the RCAC scale was understandable,
acceptable, relevant, and covered the concepts/domains intended.J Sex Med 2019;16:1049e1059Body Image
Body image was measured using the Body Image Scale (BIS),
which assesses body image discomfort associated with cancer.10
The BIS consists of 10 items, and responses are given on a 4-
point scale, from “Not at all” (0)e“Very much”,3 with higher
scores indicating a more negative body image. A clinically rele-
vant high level of negative body image is deﬁned as a summary
score >10.10,32 The BIS has shown high test-retest reliability and
good internal consistency (Cronbach’s a ¼ 0.93) in a sample of
patients with cancer.10
Health-Related Quality of Life (QOL)
Health-related QoL was measured using the EORTC QLQ-
C30 version 3.0 (QLQ-30-v3.0), which is a 30-item question-
naire developed to assess the QoL of persons with cancer.33,34
The QLQ-30 has demonstrated good psychometric properties
in cancer populations.33,35 In the current study the summary
score (higher values reﬂect better QoL) for the QLQ-30 was used
according to the EORTC QLQ-C30 Scoring Manual (3rd edi-
tion) (2001) and Giesinger et al.34Statistical Analyses
Fisher’s exact test was used to analyze differences between re-
sponders and non-responders. Sexual dysfunction and reproductive
concerns were calculated using descriptive statistics. The relation-
ships between the domains of the SexFS and the dimensions of the
RCAC were analyzed using Pearson’s correlation coefﬁcient. Pre-
dictors of sexual dysfunction and reproductive concerns were
analyzed usingmultivariable linear regression, with effects expressed
as unstandardized regression coefﬁcients, b, and overall model ﬁt
expressed by the R2. For sexual dysfunction, the 3 domains “Erectile
dysfunction,” “Interest in sexual activity,” and “Satisfaction with sex
life”were used asmodel outcomes. For reproductive concerns, the 6
dimensions were used as model outcomes. The same variables were
included as predictors in all models: age (continuous), have children
(yes/no), currently partnered (yes/no), time since diagnosis
(continuous), fertility preservation (yes/no), wish for (additional)
children (yes/uncertain/no), satisfaction with sex life before cancer
Table 2. Patient-Reported Outcomes Measurement Information
System Sexual Function and Satisfaction measure version 2.0 for
young men diagnosed with testicular cancer
n (%)
Have had sexual activity
past 30 days (n ¼ 110)
106 (96.4)
Have had sexual activity with partner
past 30 days (n ¼ 106)
74 (69.8)
Sexual dysfunction domains*,†
Erectile function (n ¼ 106) 8 (8)
Satisfaction with sex life (n ¼ 106) 19 (18)
Sexual interest (n ¼ 109) 18 (17)
1 domain over cutoff for dysfunction 29 (26)
2 domains over cutoff for dysfunction 11 (11)
*Transformed to T-score with mean ¼ 50 and SD ¼ 10 corresponding to the
population of U.S. adults who have been sexually active in the past 30 days.
†Dysfunction deﬁned as 1 SD below 50.
Table 3. Reasons for not having had sexual activity with a partner
during the past 30 days (n ¼ 32)
Reasons* n (%)
Lack of partner 10 (31)
Being too tired 10 (31)
Feeling unattractive 7 (22)
Lack of interest in sexual activity 7 (22)
Not enough time/too busy 7 (22)
Erectile problems or other problems with the penis 4 (13)
Partner unavailable 2 (6)
Does not enjoy sexual activities 1 (3)
Do not want to risk a pregnancy 1 (3)
Health issues 1 (3)
Medication affecting sexual desire 1 (3)
Other 6 (18)
*Question posed to participants who reported not having had sexual activity
with a partner during the past 30 days. Reasons speciﬁed as other included
have children, mental health issues, partner uninterested in sex, pregnant
partner.
1054 Ljungman et al(low/high), BIS total score (continuous), QLQ-30-summary score
(continuous variable), stage of disease (stage I/>stage I), tumor type
(seminom/non-seminom), cancer treatment (chemotherapy/no
chemotherapy). The variable “Satisfaction with sex-life before
cancer” was transformed to a dichotomous variable to facilitate
interpretation when used as a predictor in the regression models
according to the following principle: response 1e3 determined “low
satisfaction” and 4e5 “high satisfaction.” The models were evalu-
ated using signiﬁcance level P < .05 and R2. All statistical analyses
were performed using SPSS Statistics for Windows, version 24
(IBM Corp., Armonk, NY, USA).
Missing value analyses were performed by visualizing the
pattern of missing data, by calculating descriptive statistics
(mean, SD, frequency), and by hypothesis testing per variable
grouped by missing and observed values. The analyses indicated
no signiﬁcant or systematic patterns.Table 4. Reproductive Concerns After Cancer scale for young men
diagnosed with testicular cancer
Mean (SD)*
Cut off > 4,
n(%)
Fertility potential (n ¼ 110) 2.4 (1.2) 12 (11)
Partner disclosure (n ¼ 109) 2.3 (1.2) 10 (9)
Child’s health (n ¼ 110) 2.5 (1.3) 12 (11)
Personal health (n ¼ 110) 2.2 (0.9) 1 (1)
Acceptance (n ¼ 110) 2.5 (1.1) 12 (11)
Achieving pregnancy (n ¼ 110) 2.2 (0.90) 2 (2)
1 dimension above cutoff* 31 (28)
2 dimensions above cutoff* 11 (10)
*Dimensions calculated using all available data.RESULTS
Participants
Of the 224 individuals matching the inclusion criteria, 111
returned the questionnaire representing a response rate of 50%.
There were no signiﬁcant differences between responders and
non-responders with regard to age, time since diagnosis, treat-
ment (chemotherapy vs no chemotherapy), clinical stage of the
disease (stage I vs >stage I), or tumor type (seminom vs non-
seminom).
Mean age at diagnosis was 30.1 years (SD 5.6; range 16e39),
and mean age at study participation was 32.1 years (SD 5.5;
range 18e42). Sweden was the birth-country for 91% of the
participants, and mean number of days since diagnosis was 739
(SD 106, range 550e914). 92% of the participants were not on
any current cancer treatment. Sexual orientation was declared as
mainly heterosexual by 95% and mainly homosexual by 3% of
the participants. Furthermore, 82% had a partnered relationship,48% had children, and 65% wished for (additional) children in
the future. 4 of 5 had conducted fertility preservation, and 50%
had received chemotherapy previously. Total summary score for
BIS was 4.6 (SD 6.2; Table 1).Prevalence Of Sexual Dysfunction and
Reproductive Concerns
1 domain of sexual dysfunction was reported by one-fourth
of the participants (26%), and 1 in 10 (11%) reported 2 do-
mains of sexual dysfunction (Table 2). Erectile dysfunction was
reported by 8% of the participants. Dysfunction related to
satisfaction with sex life was reported by 18%, and dysfunction
related to sexual interest was reported by 17%. Most participants
had been sexually active in the past month. The most common
reasons why participants (n ¼ 32) had not had sex with a partner
(besides lack of partner) during the past 30 days were being too
tired, feeling unattractive, lack of interest in sexual activity, and
not having enough time/being too busy (Table 3).J Sex Med 2019;16:1049e1059
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Sex and Reproduction After Testicular Cancer 1055Approximately 1 of 4 participants (28%) reported a high level
of reproductive concerns in 1 dimension (ie, a mean score >4
in 1 of the 6 dimensions), and 1 in 10 (10%) reported a high
level of concerns in 2 dimensions (ie, a mean score >4 in 2 of
the 6 dimensions; Table 4). With regard to type of concerns,
11% reported a high level in the dimensions “Fertility potential,”
“Child’s health,” and “Acceptance.” A total of 9% of the par-
ticipants reported a high level in the dimension “Partner
disclosure.” For the remaining 2 dimensions, very few partici-
pants scored above the cutoff.
Combining the above results, 48 participants (43%) were
found to report either sexual dysfunction or high levels of
reproductive concerns in 1 dimension. Among these, 1 in 4
(n ¼ 12) reported both types of problems. Correlations between
the domains of sexual function and dimensions of reproductive
concerns were small to medium, ranging from 0.002 to 0.38.
The highest correlation was observed between the SexFS domain
“Erectile function” and the RCAC dimension “Partner
disclosure.”Predictors of Sexual Dysfunction and Reproductive
Concerns
Results from the multivariable linear regression models are
shown in Tables 5 and 6. The models of sexual dysfunction
explained 24e51% of the variance in the outcomes, whereas the
models of reproductive concerns explained 23e37% of the
variance in the outcomes.
Model results showed that higher age predicted lower levels of
sexual interest and lower levels of satisfaction with sex life.
Having a partner, however, predicted a higher satisfaction with
sex life. Both higher sexual interest and satisfaction with sex life
were related to higher satisfaction with sex life before cancer. For
erectile function, a higher health-related quality of life was
associated with higher function. Last, having a negative body
image was associated with dissatisfaction with sex life.
For reproductive concerns, having a negative body image was
related to more concerns in the dimensions “Fertility potential,”
“Partner disclosure,” and “Child’s health.” Having had fertility
preservation predicted higher levels of reproductive concerns in
the dimensions “Personal health” and “Achieving pregnancy.” A
wish for (more) children in the future was associated with lower
levels of acceptance of possible infertility, whereas higher age
predicted higher levels of acceptance.DISCUSSION
The results from this study show that the majority of young
men diagnosed with testicular cancer do not report sexual
problems or reproductive concerns approximately 2 years after
diagnosis. Still, about 1 in 4 report sexual dysfunction in 1
domain, and 1 in 4 report reproductive concerns in 1
dimension.
Table 6. Multivariable linear models for the SexFS domains for young men diagnosed with testicular cancer
Predictor variable*
b (95% CI) Sexual interest Erectile function Satisfaction with sex life
Age L0.54† (L1.02, L0.05) 0.07 (0.24, 0.38) L0.41† (L0.76, L0.07)
Partner 0.18 (6.51, 6.87) 0.59 (4.80, 3.63) 4.8† (0.12, 9.49)
QLQ-30 0.10 (0.12, 0.32) 0.16† (0.03, 0.30) 0.06 (0.10, 0.21)
BIS 0.27 (0.76, 0.22) 0.30 (0.61, 0.02) L0.42† (L0.77, L0.07)
Satisfaction with sex life before cancer 5.66† (0.71, 10.60) 0.96 (4.18, 2.27) 8.31‡ (4.73, 11.89)
R2 .24 .33 .51
BIS ¼ Body Image Scale; QLQ-30 ¼ EORTC QLQ-C30 version 3.0; SexFS ¼ Sexual Function and Satisfaction measure version 2.0.
Statistically signiﬁcant b and CI marked in bold. Non-signiﬁcant predictors included in models: Chemotherapy, Fertility preservation, Have children, Stage of
disease, Time since diagnosis, Tumor type, and Wish for children in the future.
*The following coding was used for the dichotomous predictor variables: Partner: yes ¼ 1, no ¼ 0; Satisfaction with sex life before cancer: high ¼ 1, low ¼ 0.
For the continuous predictor variables: Higher values on QOL implies higher health-related QoL, higher levels of BIS implies more negative body image.
†P < .05.
‡P < .001.
1056 Ljungman et alThe prevalence of sexual dysfunction (26%) should be
compared with the prevalence of (any) sexual problems in the
general male population (all ages), which is about 15% in the
Unites States.36 Our results, thus, indicate an increased occur-
rence of sexual dysfunction after a diagnosis of testicular cancer
in young men. Among study participants, about 1 in 5 reported
dissatisfaction with sex life or low sexual interest, which can be
compared to 13e14% of young men in the general U.S. pop-
ulation, who report a low interest in sexual activities.37 In
contrast, the prevalence of erectile dysfunction corresponds to
prevalence rates in the general population of young men
(8e11%)38 and, thus, indicates that erectile function is preserved
in young men diagnosed with testicular cancer. This result differs
from a previous ﬁnding for older survivors of testicular cancer
where erectile function has been reported to be compromised;
however, lack of reliable norms for the measures used in that
study hampers conclusions.8 Besides comparing prevalence rates,
the mean scores in the domains can be compared with results
from the general population. In each PROMIS domain, the score
50 represents the mean value for the whole U.S. population (all
ages). To improve comparisons, however, we used norm values
for a younger male population. Such values have been reported
for the SexFS, with ﬁgures indicating an overall higher sexual
function in young men (under the age of 44) as compared with
the whole general population.27 Using these comparison values,
the mean scores reported in the present study (49.8e51.6) are
lower than the mean scores in these domains for the age-matched
norms (52.1e57.0).27 Thus, in sum, our results indicate that
sexual problems are more common among young men who have
been diagnosed with testicular cancer than among young men in
the general population. Interestingly, this seems to mainly
concern the more psychological aspects of sexual function, that
is, sexual interest and satisfaction with sex life, whereas erectile
function appears to be less affected.
28% of the participants reported a high level of reproductive
concerns in 1 dimension of the RCAC. Although there is a lackof studies examining these concerns in men diagnosed with
cancer, the present ﬁgures are much lower compared with
prevalence rates reported by women after cancer, ranging from
60e65%.24,25 These results could be related to the speciﬁc
context of being diagnosed with testicular cancer and the rela-
tively favorable prognosis this implies for both survival and
fertility potential. The results could, however, also be explained
by gender differences in terms of worry tendency, because
women overall have been found to report higher levels of worry
as compared with men.39 It should also be acknowledged that
“reproductive concerns” is a multidimensional concept that in-
cludes concerns related to both reproduction and parenthood
following cancer. The most common areas of reproductive
concerns among men in this study were “Fertility potential,”
“Child’s health,” and “Acceptance,” reported by 11%, respec-
tively. Future studies are needed to conﬁrm the prevalence of
these concerns after testicular cancer, as well as after other cancer
diagnoses among men. Our results show that 1 of 4 young men
reported high levels of reproductive concerns in 1 areas at 2
years after a diagnosis of testicular cancer, which should be
acknowledged during follow-up care.
Sexual function and reproductive concerns were found to be
associated, to a limited degree, with the largest correlation seen
between the domain “Erectile function” and the RCAC
dimension “Partner disclosure” (r ¼ 0.38). In a previous study by
our group on women with breast cancer,24 correlations <0.21
were seen between sexual function and reproductive concerns.
The current results, thus, suggest these issues to be somewhat
more associated in young men after testicular cancer, although
the group who reported both a sexual dysfunction and a high
level of reproductive concerns was rather small (11%). Still, our
ﬁnding that 43% of young men diagnosed with testicular cancer
reported either a sexual dysfunction or a high level of repro-
ductive concerns should be acknowledged in survivorship care.
Model results showed that predictors varied between the
different types of sexual problems. Older age predicted lowerJ Sex Med 2019;16:1049e1059
Sex and Reproduction After Testicular Cancer 1057sexual interest and satisfaction with sex life, which conﬁrms
previous ﬁndings for men with testicular cancer.8 Having a
partner, on the other hand, was related to a higher satisfaction
with sex life, which is consistent with ﬁndings identifying a
positive impact of partnership on sexual function after testicular
cancer.3,5 Our result that a negative body image was signiﬁcantly
associated with low sexual interest is in line with previous ﬁnd-
ings among young women with cancer24 and highlights that
body image is an important mechanism related to sexual function
among young men after a cancer diagnosis. Another important
result is that level of satisfaction with sex life before cancer turned
out to be signiﬁcantly related to both level of sexual interest and
satisfaction with sex life. Even though this variable was collected
as a retrospective assessment of the pre-cancer level of satisfac-
tion, this ﬁnding suggests potential continuity in sexual
dysfunction and that mechanisms involved in sexual problems
after cancer may not solely be cancer-speciﬁc. Last, it is impor-
tant to acknowledge that none of the clinical variables included
in the models (ie, previous chemotherapy, clinical stage of dis-
ease, tumor-type) predicted any of the outcomes with regard to
sexual function. This result supports the suggestion that psy-
chological mechanisms may be more important in relation to
sexual problems after testicular cancer than factors related to
diagnosis and treatment.8 To further improve our understanding
of this, future studies could expand models of sexual dysfunction
after a cancer diagnosis in young men to also include other po-
tential psychological mechanisms involved in these issues, such as
intolerance of uncertainty, emotional avoidance, feelings of loss
and grief related to the cancer experience, and levels of depression
and anxiety.
Several variables were related to reproductive concerns.Higher age
predicted lower levels of reproductive concerns in the area of
acceptance, which correspondswith previous results on age and these
types of concerns in young women after a cancer diagnosis.21Having
a partner was related to lower levels of reproductive concerns in the
area of partner disclosure, which is not a surprising ﬁnding because
participants who have a partner may have had opportunities to
“practice” these types of conversations. Interestingly, our results
showed that having had fertility preservation predicted higher levels
of concerns in the dimensions “Personal health” and “Achieving
pregnancy.” This ﬁnding contradicts results from qualitative studies
indicating that male cancer patients regard sperm banking as a proof
that care providers believed that they would survive,40 as a “safety
net,” and a buffer against anxiety over possible future infertility.18,19
However, recent results in young women with cancer have shown
similar results with higher levels of reproductive concerns among
those who had used fertility preservation.41 The authors suggested
that these ﬁndings could be explained by the increased information
about the adverse treatment effects on reproductive potential that this
group of women may have received. Although such an explanation
could apply also tomale patients, previous results have suggested that
men perceive sperm banking to be performed in haste and not always
after discussion and patient involvement in decision-making.18,42J Sex Med 2019;16:1049e1059Another possible explanation could be that there are other factors,
not included in the model, that correlate both with having had
fertility preservation and with higher levels of reproductive concerns.
1 such potential factor could be “intolerance of uncertainty,”which is
a psychological mechanism known to predict higher levels of
worry.43 This could be a factor explaining both a higher level of
reproductive concerns and the choice to preserve sperm. Men who
choose to bank sperm may also be more in touch with vulnerable
feelings concerning attempts to achieve a pregnancy and future health
risks. Last, the association between negative body image and high
levels of reproductive concerns underscores that aspects of repro-
duction are closely related to howmen perceive their body, including
their masculinity. Previous qualitative research has identiﬁed that
fertility and sexual virility often are inherently linked in youngmen,17
and negative body image (including a perceived loss of masculinity)
may be a joint factor explaining both these processes. Our results give
some support to such a notion; however, body image, masculinity,
and other psychological mechanisms potentially involved in sexual
and reproductive sequelae after cancer should be evaluated further in
future studies.Methodologic Considerations
A strength of this study is the use of the Swedish National
Quality Registry for Testicular Cancer. Using this registry
allowed collection of high-quality data, with excellent coverage
for a year-cohort of all young men diagnosed with testicular
cancer in Sweden. However, because testicular cancer is rather
uncommon, the sample size (n ¼ 111) might still have been too
small to precisely characterize some relationships in the regres-
sion models. It should be noted that we did not adjust for
multiple comparisons in the models, and, thus, the signiﬁcant
associations should be interpreted with some caution. The
response rate of 50% should also be considered with regard to
the risk of selection bias. Importantly, analyses of non-responders
revealed no correlation with background variables, which lowers
this risk and increases the external validity of the results.
Furthermore, a strength of the study is the use of validated in-
struments and reliable comparison data that enhance the study
quality and enables comparisons. It should be acknowledged that
the American norms used to analyze data from the SexFS might
not correspond exactly to the Swedish population and that using
an age-matched Swedish control group would have strengthened
the study design. The clinical validity of the cutoff score that we
used to deﬁne sexual dysfunction (1 SD below the mean score as
recommended by the PROMIS Network [http://www.
nihpromis.org/]) is reasonable but yet to be conﬁrmed. The
conclusions with regard to the prevalence of sexual dysfunction
and reproductive concerns should, therefore, be drawn with
some caution. Additionally, the single item assessing satisfaction
with sex life before cancer is subject to recall bias and is not fully
comparable to the SexFS domain “Satisfaction with sex life.” The
single item “Satisfaction with sex life previous to cancer” was,
thus, useful mainly as a predictor in the regression models to
1058 Ljungman et alfacilitate interpretation of the model results. Last, it should be
mentioned that self-reported sexual function, reproductive con-
cerns, body image, and QoL were collected simultaneously in the
survey, and that future longitudinal studies should be conducted
to validate the relationships between these concepts.CONCLUSION
Although the current study shows that most young men
with testicular cancer do not experience sexual dysfunction or
high levels of reproductive concerns at 2 years after diagnosis,
the subgroup who does experience such problems should be
acknowledged. Furthermore, our results indicate that clinical
factors do not predict these outcomes; rather, psychological
factors were the main mechanisms involved in sexual problems
and reproductive concerns after testicular cancer in young
men. Negative body image was identiﬁed as 1 such factor;
however, to fully map and understand the psychological fac-
tors involved in these issues, more research will be needed.
Last, to improve care provided to this population in the
future, men suffering from sexual dysfunction or reproductive
concerns in the aftermath of testicular cancer should be
offered treatment accordingly.
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